Press Release

This user hasn't shared any profile information

Merck announced this week that V114, the company’s investigational 15-valent pneumococcal conjugate vaccine, has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration...

To the list of woes brought on by Venezuela’s economic and political turmoil, add one more: a crippled national vaccination program has resulted in record-high numbers in cases of measles, diphtheria...

Biotech company, Valneva SE, announced today positive initial booster data and final Phase 1 data for its leading, unique Lyme disease vaccine candidate VLA15. To investigate whether a VLA15 booster...

Vaccinating laboratory mice with Streptococcus mitis bacteria prevents their virulent sibling, Streptococcus pneumoniae from infecting the mice. The research suggests that vaccination of humans with...

Clark County Public Health is continuing its measles outbreak investigation. Since Jan. 1, we have identified 36 confirmed cases and 12 suspect cases. Public Health has also identified one new location...

Medicines for Malaria Venture (MMV) and the Drugs for Neglected Diseases initiative (DNDi) have launched the Pandemic Response Box to provide researchers with free access to 400 diverse compounds...

The Ministry of Health, Wellness and the Environment wishes to report that laboratory testing at the Caribbean Public Health Agency (CARPHA) has confirmed Dengue Type 3 in Antigua and Barbuda. The total...

Takeda Pharmaceutical Company Limited today announced that the pivotal Phase 3 trial of its dengue vaccine candidate met the primary efficacy endpoint. This first analysis of the Tetravalent Immunization...

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet. Eighteen healthy adults...

Researchers from North Carolina State University have developed an algorithm that could give pig farms advance notice of porcine epidemic diarrhea virus (PEDV) outbreaks. The proof-of-concept algorithm...